| Autor: |
Dubé GP; Cardiovascular Research, Biopure Corporation, Cambridge, Massachusetts 02141, USA. gdube@biopure.com, Vranckx P, Greenburg AG |
| Jazyk: |
angličtina |
| Zdroj: |
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology [EuroIntervention] 2008 May; Vol. 4 (1), pp. 161-5. |
| DOI: |
10.4244/eijv4i1a26 |
| Abstrakt: |
Clinical and preclinical studies have revealed a diverse array of indications in which the effectiveness of HBOC-201 has been demonstrated or appears likely. Included among these are indications involving cardiac and peripheral ischaemia in which this oxygen therapeutic may prove to be an important tool in the armamentarium of the cardiologist and surgeon. Preclinical studies and clinical trials are under way to further delineate and optimise the role of HBOC-201 as an oxygen therapeutic in cardiovascular medicine. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
